50+ Global Enterprises Count on Evalueserve IP and R&D
Osaka & Tokyo Seminar
From Patents to Revenue: Practical Strategies to Unlock IP Value
June 2 and June 5, 2026
Where We Focus
Drive Growth with Strategic IP and R&D Synergy.
From strategy to execution, delivering services that accelerate innovation and market success.
Strengthen Your
IP Strategy & Portfolio Positioning
Assess portfolio strength, competitive positioning to maximize IP value and strategic advantage.
Accelerate Your
R&D & Innovation
Pipeline
Evidence-based insights to guide R&D pipelines, ecosystem, and technology investments.
Navigate Complex
Scientific & Regulatory Pathways
Structured evaluation of evidence, safety, and regulatory strategy.
Optimize Your Processes With
AI-Assisted Workflows
Streamlined patent searches, competitive insights, and innovation scouting powered by AI.
Awards & Recognition
Recognized for "strength in domain-specific AI" *
* Chartis
eBook
How Can You Mitigate Risks in Medical Device Development
Learn how to navigate safety challenges in medical device development with trusted experts.
Success Story
Driving Revenue with Precision: AI-Assisted Patent Licensing Workflow
Discover how a global technology leader streamlined patent licensing with Evalueserve.
Our Clients
Success Stories.
Strategic Patentability Enhancement for a Manufacturing Leader
Sustainable Innovation in Polymer Production
Enhancing Chemical Safety and Compliance Through Strategic Collaboration
- SWIPE
Related Resources
Latest Insights from the IP and R&D World.
Why the Food Industry Must Rethink Growth?
Why the Food Industry must rethink growth as Japan’s shrinking and aging population reshapes demand shifting from volume to value accelerating premiumization and redefining long-term F&B strategies.
The Three-Legged Stool of Enterprise AI Adoption
Enterprise AI Adoption is failing to deliver expected ROI for most organizations—discover why success depends on combining domain expertise, technology muscle, and trusted relationships, not just AI models.
Why Patent Monetization Should Be Treated as a Capital Allocation Decision
Why patent monetization should be treated as a capital allocation decision. Learn how to maximize IP value through risk‑adjusted strategy, not litigation alone.
Why Operational IP May Be Becoming More Strategic in Japan and Korea
Why operational IP is becoming a strategic differentiator in Japan and Korea: from patent examination predictability to enforcement efficiency, discover how operational IP performance is reshaping competitive advantage in advanced innovation economies.
- SWIPE
